123 related articles for article (PubMed ID: 16856205)
1. Apoptosis resistance in ulcerative colitis: high expression of decoy receptors by lamina propria T cells.
Fayad R; Brand MI; Stone D; Keshavarzian A; Qiao L
Eur J Immunol; 2006 Aug; 36(8):2215-22. PubMed ID: 16856205
[TBL] [Abstract][Full Text] [Related]
2. Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2.
Mérino D; Lalaoui N; Morizot A; Schneider P; Solary E; Micheau O
Mol Cell Biol; 2006 Oct; 26(19):7046-55. PubMed ID: 16980609
[TBL] [Abstract][Full Text] [Related]
3. Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells.
Wendling U; Walczak H; Dörr J; Jaboci C; Weller M; Krammer PH; Zipp F
Cell Death Differ; 2000 Jul; 7(7):637-44. PubMed ID: 10889508
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of a set of monoclonal antibodies to TRAIL and TRAIL receptors DR4, DR5, DcR1, and DcR2.
Liu XS; Zhu Y; Han WN; Li YN; Chen LH; Jia W; Song CJ; Liu F; Yang K; Li Q; Jin BQ
Hybrid Hybridomics; 2003 Apr; 22(2):121-5. PubMed ID: 12831538
[TBL] [Abstract][Full Text] [Related]
5. TNF-alpha-related apoptosis-inducing ligand decoy receptor DcR2 is targeted by androgen action in the rat ventral prostate.
Vindrieux D; Réveiller M; Florin A; Blanchard C; Ruffion A; Devonec M; Benahmed M; Grataroli R
J Cell Physiol; 2006 Mar; 206(3):709-17. PubMed ID: 16245307
[TBL] [Abstract][Full Text] [Related]
6. p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha.
Sheikh MS; Burns TF; Huang Y; Wu GS; Amundson S; Brooks KS; Fornace AJ; el-Deiry WS
Cancer Res; 1998 Apr; 58(8):1593-8. PubMed ID: 9563466
[TBL] [Abstract][Full Text] [Related]
7. Ultraviolet light downregulates CD95 ligand and TRAIL receptor expression facilitating actinic keratosis and squamous cell carcinoma formation.
Bachmann F; Buechner SA; Wernli M; Strebel S; Erb P
J Invest Dermatol; 2001 Jul; 117(1):59-66. PubMed ID: 11442750
[TBL] [Abstract][Full Text] [Related]
8. Tumor-specific down-regulation of the tumor necrosis factor-related apoptosis-inducing ligand decoy receptors DcR1 and DcR2 is associated with dense promoter hypermethylation.
van Noesel MM; van Bezouw S; Salomons GS; Voûte PA; Pieters R; Baylin SB; Herman JG; Versteeg R
Cancer Res; 2002 Apr; 62(7):2157-61. PubMed ID: 11929838
[TBL] [Abstract][Full Text] [Related]
9. Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils.
Kamohara H; Matsuyama W; Shimozato O; Abe K; Galligan C; Hashimoto S; Matsushima K; Yoshimura T
Immunology; 2004 Feb; 111(2):186-94. PubMed ID: 15027904
[TBL] [Abstract][Full Text] [Related]
10. Expression of tumor necrosis factor- alpha -related apoptosis-inducing ligand and its proapoptotic receptors is down-regulated during gastric infection with virulent cagA+/vacAs1+ Helicobacter pylori strains.
Neu B; Rad R; Reindl W; Neuhofer M; Gerhard M; Schepp W; Prinz C
J Infect Dis; 2005 Feb; 191(4):571-8. PubMed ID: 15655781
[TBL] [Abstract][Full Text] [Related]
11. TRAIL induces death of human oligodendrocytes isolated from adult brain.
Matysiak M; Jurewicz A; Jaskolski D; Selmaj K
Brain; 2002 Nov; 125(Pt 11):2469-80. PubMed ID: 12390973
[TBL] [Abstract][Full Text] [Related]
12. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors.
Sheridan JP; Marsters SA; Pitti RM; Gurney A; Skubatch M; Baldwin D; Ramakrishnan L; Gray CL; Baker K; Wood WI; Goddard AD; Godowski P; Ashkenazi A
Science; 1997 Aug; 277(5327):818-21. PubMed ID: 9242611
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory cytokine regulation of TRAIL-mediated apoptosis in thyroid epithelial cells.
Bretz JD; Mezosi E; Giordano TJ; Gauger PG; Thompson NW; Baker JR
Cell Death Differ; 2002 Mar; 9(3):274-86. PubMed ID: 11859410
[TBL] [Abstract][Full Text] [Related]
14. TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention.
Ahmad M; Shi Y
Oncogene; 2000 Jul; 19(30):3363-71. PubMed ID: 10918593
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis of TRAIL receptors using monoclonal antibodies.
Griffith TS; Rauch CT; Smolak PJ; Waugh JY; Boiani N; Lynch DH; Smith CA; Goodwin RG; Kubin MZ
J Immunol; 1999 Mar; 162(5):2597-605. PubMed ID: 10072501
[TBL] [Abstract][Full Text] [Related]
16. Application of flow cytometry to molecular medicine: detection of tumor necrosis factor-related apoptosis-inducing ligand receptors in acute myeloid leukaemia blasts.
Cappellini A; Mantovani I; Tazzari PL; Grafone T; Martinelli G; Cocco L; Martelli AM
Int J Mol Med; 2005 Dec; 16(6):1041-8. PubMed ID: 16273284
[TBL] [Abstract][Full Text] [Related]
17. IFN-gamma induces cell death in human hepatoma cells through a TRAIL/death receptor-mediated apoptotic pathway.
Shin EC; Ahn JM; Kim CH; Choi Y; Ahn YS; Kim H; Kim SJ; Park JH
Int J Cancer; 2001 Jul; 93(2):262-8. PubMed ID: 11410875
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptors, and the soluble receptor osteoprotegerin in human gestational membranes and amniotic fluid during pregnancy and labor at term and preterm.
Lonergan M; Aponso D; Marvin KW; Helliwell RJ; Sato TA; Mitchell MD; Chaiwaropongsa T; Romero R; Keelan JA
J Clin Endocrinol Metab; 2003 Aug; 88(8):3835-44. PubMed ID: 12915677
[TBL] [Abstract][Full Text] [Related]
19. Visilizumab induces apoptosis of mucosal T lymphocytes in ulcerative colitis through activation of caspase 3 and 8 dependent pathways.
Yu QT; Saruta M; Papadakis KA
Clin Immunol; 2008 Jun; 127(3):322-9. PubMed ID: 18424236
[TBL] [Abstract][Full Text] [Related]
20. Control of apoptosis signaling by Apo2 ligand.
Marsters SA; Pitti RA; Sheridan JP; Ashkenazi A
Recent Prog Horm Res; 1999; 54():225-34. PubMed ID: 10548878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]